![](/img/cover-not-exists.png)
Should muraglitazar be approved by the FDA for the treatment of type 2 diabetes?
Doherty, RebeccaVolume:
2
Language:
english
Journal:
Nature Clinical Practice Endocrinology & Metabolism
DOI:
10.1038/ncpendmet0057x
Date:
February, 2006
File:
PDF, 148 KB
english, 2006